CA-LOGITECH
SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the third quarter of Fiscal Year 2024.
- Sales were $1.26 billion, down 1 percent in US dollars and 3 percent in constant currency, compared to the prior year.
- GAAP operating income was $222 million, up 26 percent compared to the prior year. Non-GAAP operating income was $248 million, up 22 percent compared to the prior year.
- GAAP earnings per share (EPS) was $1.55, up 80 percent compared to the prior year. Non-GAAP EPS was $1.53, up 34 percent compared to the prior year.
- Cash flow from operations was $443 million, up 58 percent compared to the prior year. The quarter-ending cash balance was $1.41 billion. In the quarter, the Company returned $188 million of cash to shareholders through share repurchases.
“We delivered solid results in our third quarter,” said Hanneke Faber, Logitech chief executive officer. “Our teams executed well, continuing our long record of exceptional product innovation, market share gains, strong operational discipline and prudent financial management. But we will not be satisfied until we return to top line growth.”
“Our third-quarter results show our continued focus on operational discipline,” said Chuck Boynton, Logitech chief financial officer. “While revenue declined 3% in constant currency, we delivered strong gross margins of 42.3% and grew profitability. We generated $443 million in operating cash flow in the quarter and returned a total of $188 million to our shareholders through share repurchases.”
Outlook
Logitech raised its full-year outlook for Fiscal Year 2024:
|
Previous FY24 outlook |
New FY24 outlook |
Sales |
$4.0 - $4.15 billion |
$4.2 - $4.25 billion |
Sales growth / (decline) (in US dollars, year over year) |
(12%) - (9%) |
(7%) - (6%) |
Non-GAAP operating income |
$525 - $575 million |
$610 - $660 million |
Non-GAAP op. inc. growth / (decline) (year over year) |
(11%) - (2%) |
4% - 12% |
Financial Results Videoconference and Webcast
Logitech will hold a financial results videoconference to discuss the results for Q3 Fiscal Year 2024 on Tuesday, January 23, 2024 at 8:30 a.m. Eastern Standard Time and 2:30 p.m. Central European Time. A livestream of the event will be available on the Logitech corporate website at https://ir.logitech.com. This press release and the Q3 Fiscal Year 2024 Shareholder Letter are also available there.
Use of Non-GAAP Financial Information and Constant Currency
To facilitate comparisons to Logitech’s historical results, Logitech has included non-GAAP adjusted measures in this press release, which exclude share-based compensation expense, amortization of intangible assets, acquisition-related costs, restructuring charges, net, loss on investments, non-GAAP income tax adjustment, and other items detailed under “Supplemental Financial Information” after the tables below and posted to our website at https://ir.logitech.com. Logitech also presents percentage sales growth in constant currency (“CC”), a non-GAAP measure, to show performance unaffected by fluctuations in currency exchange rates. Percentage sales growth in constant currency is calculated by translating prior period sales in each local currency at the current period’s average exchange rate for that currency and comparing that to current period sales. Logitech believes this information, used together with the GAAP financial information, will help investors to evaluate its current period performance, outlook and trends in its business. With respect to the Company’s outlook for non-GAAP operating income, most of these excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy. Therefore, no reconciliation to the GAAP amounts has been provided for the full Fiscal Year 2024 non-GAAP operating income outlook.
Public Dissemination of Certain Information
Recordings of Logitech’s earnings videoconferences and certain events Logitech participates in or hosts, with members of the investment community are posted on the company’s investor relations website at https://ir.logitech.com. Additionally, Logitech provides notifications of news or announcements regarding its operations and financial performance, including its filings with the Securities and Exchange Commission (SEC), investor events, and press and earnings releases as part of its investor relations website. Logitech intends to use its investor relations website as means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. Logitech’s corporate governance information also is available on its investor relations website.
About Logitech
Logitech helps all people pursue their passions and is committed to doing so in a way that is good for people and the planet. We design hardware and software solutions that help businesses thrive and bring people together when working, creating, gaming and streaming. Brands of Logitech include Logitech, Logitech G, Streamlabs and Ultimate Ears. Founded in 1981, and headquartered in Lausanne, Switzerland, Logitech International is a Swiss public company listed on the SIX Swiss Exchange (LOGN) and on the Nasdaq Global Select Market (LOGI). Find Logitech at www.logitech.com, the company blog or @logitech.
This press release contains forward-looking statements within the meaning of U.S. federal securities laws, including, without limitation, statements regarding: our preliminary financial results for the three and nine months ended December 31, 2023, Fiscal Year 2024 outlook for sales and non-GAAP operating income, and related assumptions. The forward-looking statements in this press release are subject to risks and uncertainties that could cause Logitech’s actual results and events to differ materially from those anticipated in these forward-looking statements, including, without limitation: macroeconomic and geopolitical conditions and other factors and their impact, for example changes in inflation levels and monetary policies; our expectations regarding our expense reduction efforts, including the timing thereof; changes in secular trends that impact our business; if our product offerings, marketing activities and investment prioritization decisions do not result in the sales, profitability or profitability growth we expect, or when we expect it; if we fail to innovate and develop new products in a timely and cost-effective manner for our new and existing product categories; if we do not successfully execute on our growth opportunities or our growth opportunities are more limited than we expect; the effect of demand variability, supply shortages and other supply chain challenges; the effect of logistics challenges, including disruptions in transportation lines; the effect of pricing, product, marketing and other initiatives by our competitors, and our reaction to them, on our sales, gross margins and profitability; if we are not able to maintain and enhance our brands; if our products and marketing strategies fail to separate our products from competitors’ products; if we do not efficiently manage our spending; our expectations regarding our restructuring efforts, including the timing thereof; if there is a deterioration of business and economic conditions in one or more of our sales regions or product categories, or significant fluctuations in exchange rates; changes in trade regulations, policies and agreements and the imposition of tariffs that affect our products or operations and our ability to mitigate; if we do not successfully execute on strategic acquisitions and investments; risks associated with acquisitions; and the effect of changes to our effective income tax rates. A detailed discussion of these and other risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in Logitech’s periodic filings with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K for the fiscal year ended March 31, 2023, our Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, and other reports filed with the SEC, available at www.sec.gov, under the caption Risk Factors and elsewhere. Logitech does not undertake any obligation to update any forward-looking statements to reflect new information or events or circumstances occurring after the date of this press release.
Note that unless noted otherwise, comparisons are year over year.
Logitech and other Logitech marks are trademarks or registered trademarks of Logitech Europe S.A. and/or its affiliates in the U.S. and other countries. All other trademarks are the property of their respective owners. For more information about Logitech and its products, visit the company’s website at www.logitech.com.
LOGITECH INTERNATIONAL S.A. |
|
|
|
|
|
|
|
|
||||||||
PRELIMINARY RESULTS* |
|
|
|
|
||||||||||||
(In thousands, except per share amounts) - unaudited |
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
|
|
Three months ended
|
|
Nine months ended
|
||||||||||||
GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
||||||||
Net sales |
|
$ |
1,255,473 |
|
|
$ |
1,269,925 |
|
$ |
3,286,980 |
|
|
$ |
3,578,741 |
|
|
Cost of goods sold |
|
|
726,252 |
|
|
|
789,489 |
|
|
|
1,937,367 |
|
|
|
2,193,735 |
|
Amortization of intangible assets |
|
|
2,441 |
|
|
|
3,168 |
|
|
|
8,569 |
|
|
|
9,355 |
|
Gross profit |
|
|
526,780 |
|
|
|
477,268 |
|
|
|
1,341,044 |
|
|
|
1,375,651 |
|
|
|
|
|
|
|
|
|
|
||||||||
Operating expenses: |
|
|
|
|
|
|
|
|
||||||||
Marketing and selling |
|
|
189,175 |
|
|
|
196,653 |
|
|
|
544,716 |
|
|
|
628,122 |
|
Research and development |
|
|
72,704 |
|
|
|
65,640 |
|
|
|
211,822 |
|
|
|
210,166 |
|
General and administrative |
|
|
39,711 |
|
|
|
29,766 |
|
|
|
116,546 |
|
|
|
92,215 |
|
Amortization of intangible assets and acquisition-related costs |
|
|
2,276 |
|
|
|
2,810 |
|
|
|
8,279 |
|
|
|
9,052 |
|
Restructuring charges, net |
|
|
839 |
|
|
|
5,654 |
|
|
|
2,562 |
|
|
|
16,471 |
|
Total operating expenses |
|
|
304,705 |
|
|
|
300,523 |
|
|
|
883,925 |
|
|
|
956,026 |
|
|
|
|
|
|
|
|
|
|
||||||||
Operating income |
|
|
222,075 |
|
|
|
176,745 |
|
|
|
457,119 |
|
|
|
419,625 |
|
Interest income |
|
|
12,826 |
|
|
|
4,665 |
|
|
|
34,508 |
|
|
|
9,573 |
|
Other income (expense), net |
|
|
189 |
|
|
|
1,406 |
|
|
|
(13,827 |
) |
|
|
(18,367 |
) |
Income before income taxes |
|
|
235,090 |
|
|
|
182,816 |
|
|
|
477,800 |
|
|
|
410,831 |
|
Provision for (benefit from) income taxes |
|
|
(9,594 |
) |
|
|
42,663 |
|
|
|
33,272 |
|
|
|
87,751 |
|
Net income |
|
$ |
244,684 |
|
|
$ |
140,153 |
|
|
$ |
444,528 |
|
|
$ |
323,080 |
|
|
|
|
|
|
|
|
|
|
||||||||
Net income per share: |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
$ |
1.57 |
|
|
$ |
0.87 |
|
|
$ |
2.82 |
|
|
$ |
1.98 |
|
Diluted |
|
$ |
1.55 |
|
|
$ |
0.86 |
|
|
$ |
2.80 |
|
|
$ |
1.96 |
|
|
|
|
|
|
|
|
|
|
||||||||
Weighted average shares used to compute net income per share: |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
|
155,933 |
|
|
|
161,244 |
|
|
|
157,568 |
|
|
|
163,042 |
|
Diluted |
|
|
157,440 |
|
|
|
162,529 |
|
|
|
158,843 |
|
|
164,427 |
||
LOGITECH INTERNATIONAL S.A. |
|
|
|
|
||||
PRELIMINARY RESULTS* |
|
|
|
|
||||
(In thousands, except per share amounts) - unaudited |
|
|
|
|
||||
|
|
|
|
|
||||
|
|
December 31 |
|
March 31, |
||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|
|
2023 |
|
|
|
2023 |
|
|
|
|
|
|
||||
Current assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
1,412,650 |
|
|
$ |
1,149,023 |
|
Accounts receivable, net |
|
|
685,777 |
|
|
|
630,382 |
|
Inventories |
|
|
447,262 |
|
|
|
682,893 |
|
Other current assets |
|
|
150,754 |
|
|
|
142,876 |
|
Total current assets |
|
|
2,696,443 |
|
|
|
2,605,174 |
|
|
|
|
|
|
||||
Non-current assets: |
|
|
|
|
||||
Property, plant and equipment, net |
|
|
119,200 |
|
|
|
121,503 |
|
Goodwill |
|
|
463,978 |
|
|
|
454,610 |
|
Other intangible assets, net |
|
|
53,724 |
|
|
|
63,173 |
|
Other assets |
|
|
326,594 |
|
|
|
316,293 |
|
Total assets |
|
$ |
3,659,939 |
|
|
$ |
3,560,753 |
|
|
|
|
|
|
||||
Current liabilities: |
|
|
|
|
||||
Accounts payable |
|
$ |
527,988 |
|
|
$ |
406,968 |
|
Accrued and other current liabilities |
|
|
673,435 |
|
|
|
643,139 |
|
Total current liabilities |
|
|
1,201,423 |
|
|
|
1,050,107 |
|
|
|
|
|
|
||||
Non-current liabilities: |
|
|
|
|
||||
Income taxes payable |
|
|
111,924 |
|
|
|
106,391 |
|
Other non-current liabilities |
|
|
156,491 |
|
|
|
146,695 |
|
Total liabilities |
|
|
1,469,838 |
|
|
|
1,303,193 |
|
|
|
|
|
|
||||
Shareholders’ equity: |
|
|
|
|
||||
Registered shares, CHF 0.25 par value: |
|
|
30,148 |
|
|
|
30,148 |
|
Issued shares — 173,106 at December 31, 2023 and March 31, 2023 |
|
|
|
|
||||
Additional shares that may be issued out of conditional capital — 50,000 at December 31, 2023 and March 31, 2023 |
|
|
|
|
||||
Additional shares that may be issued out of authorized capital — 17,311 at December 31, 2023 and March 31, 2023 |
|
|
|
|
||||
Additional paid-in capital |
|
|
60,892 |
|
|
|
127,380 |
|
Shares in treasury, at cost — 18,108 at December 31, 2023 and 13,763 at March 31, 2023 |
|
|
(1,251,314 |
) |
|
|
(977,266 |
) |
Retained earnings |
|
|
3,434,904 |
|
|
|
3,177,575 |
|
Accumulated other comprehensive loss |
|
|
(84,529 |
) |
|
|
(100,277 |
) |
Total shareholders’ equity |
|
|
2,190,101 |
|
|
|
2,257,560 |
|
Total liabilities and shareholders’ equity |
|
$ |
3,659,939 |
|
|
$ |
3,560,753 |
|
LOGITECH INTERNATIONAL S.A. |
|
|
|
|
|
|
|
|
||||||||
PRELIMINARY RESULTS* |
|
|
|
|
|
|
|
|
||||||||
(In thousands) - unaudited |
|
|
|
|
|
|
|
|
||||||||
|
|
Three months ended
|
|
Nine months ended
|
||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
||||||||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
||||||||
Net income |
|
$ |
244,684 |
|
|
$ |
140,153 |
|
|
$ |
444,528 |
|
|
$ |
323,080 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
||||||||
Depreciation |
|
|
14,739 |
|
|
|
19,410 |
|
|
|
48,874 |
|
|
|
56,698 |
|
Amortization of intangible assets |
|
|
5,074 |
|
|
|
5,929 |
|
|
|
16,583 |
|
|
|
18,173 |
|
Loss on investments |
|
|
604 |
|
|
|
1,488 |
|
|
|
12,213 |
|
|
|
13,065 |
|
Share-based compensation expense |
|
|
20,613 |
|
|
|
15,805 |
|
|
|
64,192 |
|
|
|
51,740 |
|
Deferred income taxes |
|
|
(20,623 |
) |
|
|
21,188 |
|
|
|
(9,515 |
) |
|
|
24,228 |
|
Other |
|
|
236 |
|
|
|
1,293 |
|
|
|
336 |
|
|
|
1,411 |
|
Changes in assets and liabilities, net of acquisitions: |
|
|
|
|
|
|
|
|
||||||||
Accounts receivable, net |
|
|
(11,424 |
) |
|
|
(1,638 |
) |
|
|
(46,786 |
) |
|
|
(123,547 |
) |
Inventories |
|
|
91,600 |
|
|
|
104,519 |
|
|
|
237,969 |
|
|
|
126,309 |
|
Other assets |
|
|
(8,301 |
) |
|
|
16,161 |
|
|
|
3,698 |
|
|
|
20,918 |
|
Accounts payable |
|
|
32,361 |
|
|
|
(56,494 |
) |
|
|
120,383 |
|
|
|
(134,848 |
) |
Accrued and other liabilities |
|
|
73,389 |
|
|
|
12,097 |
|
|
|
13,536 |
|
|
|
(60,060 |
) |
Net cash provided by operating activities |
|
|
442,952 |
|
|
|
279,911 |
|
|
|
906,011 |
|
|
|
317,167 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
||||||||
Purchases of property, plant and equipment |
|
|
(10,854 |
) |
|
|
(23,738 |
) |
|
|
(45,585 |
) |
|
|
(69,122 |
) |
Investment in privately held companies |
|
|
(50 |
) |
|
|
(351 |
) |
|
|
(406 |
) |
|
|
(2,626 |
) |
Acquisitions, net of cash acquired |
|
|
— |
|
|
|
(2,688 |
) |
|
|
(14,138 |
) |
|
|
(8,527 |
) |
Purchases of deferred compensation investments |
|
|
(5,345 |
) |
|
|
(2,687 |
) |
|
|
(7,893 |
) |
|
|
(5,186 |
) |
Proceeds from sales of deferred compensation investments |
|
|
5,571 |
|
|
|
2,314 |
|
|
|
8,193 |
|
|
|
4,750 |
|
Net cash used in investing activities |
|
|
(10,678 |
) |
|
|
(27,150 |
) |
|
|
(59,829 |
) |
|
|
(80,711 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
||||||||
Payment of cash dividends |
|
|
— |
|
|
|
— |
|
|
|
(182,305 |
) |
|
|
(158,680 |
) |
Payment of contingent consideration for business acquisition |
|
|
— |
|
|
|
— |
|
|
|
(5,002 |
) |
|
|
(5,954 |
) |
Purchases of registered shares |
|
|
(187,834 |
) |
|
|
(90,170 |
) |
|
|
(376,775 |
) |
|
|
(327,731 |
) |
Proceeds from exercises of stock options and purchase rights |
|
|
— |
|
|
|
3,214 |
|
|
|
15,319 |
|
|
|
16,064 |
|
Tax withholdings related to net share settlements of restricted stock units |
|
|
(2,372 |
) |
|
|
(1,992 |
) |
|
|
(28,596 |
) |
|
|
(28,734 |
) |
Other financing activities |
|
|
— |
|
|
|
— |
|
|
|
(1,116 |
) |
|
|
— |
|
Net cash used in financing activities |
|
|
(190,206 |
) |
|
|
(88,948 |
) |
|
|
(578,475 |
) |
|
|
(505,035 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
|
6,678 |
|
|
|
3,817 |
|
|
|
(4,080 |
) |
|
|
(24,006 |
) |
Net increase (decrease) in cash and cash equivalents |
|
|
248,746 |
|
|
|
167,630 |
|
|
|
263,627 |
|
|
|
(292,585 |
) |
Cash and cash equivalents, beginning of the period |
|
|
1,163,904 |
|
|
|
868,501 |
|
|
|
1,149,023 |
|
|
|
1,328,716 |
|
Cash and cash equivalents, end of the period |
|
$ |
1,412,650 |
|
|
$ |
1,036,131 |
|
|
$ |
1,412,650 |
|
|
$ |
1,036,131 |
|
LOGITECH INTERNATIONAL S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
PRELIMINARY RESULTS* |
|
|
|
|
|
|
|
|
|
|
||||||||
(In thousands) - unaudited |
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
SUPPLEMENTAL FINANCIAL INFORMATION |
|
Three months ended December 31, |
|
Nine months ended December 31, |
||||||||||||||
NET SALES |
|
2023 |
|
2022 (1) |
|
Change |
|
2023 |
|
2022 (1) |
|
Change |
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Net sales by product category: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Gaming (2) |
|
$ |
409,043 |
|
$ |
411,927 |
|
(1 |
)% |
|
$ |
957,576 |
|
$ |
1,031,876 |
|
(7 |
)% |
Keyboards & Combos |
|
|
229,432 |
|
|
220,059 |
|
4 |
|
|
|
605,201 |
|
|
648,632 |
|
(7 |
) |
Pointing Devices |
|
|
206,180 |
|
|
199,106 |
|
4 |
|
|
|
572,310 |
|
|
567,589 |
|
1 |
|
Video Collaboration |
|
|
169,522 |
|
|
173,516 |
|
(2 |
) |
|
|
461,257 |
|
|
534,347 |
|
(14 |
) |
Webcams |
|
|
85,851 |
|
|
94,252 |
|
(9 |
) |
|
|
249,273 |
|
|
305,532 |
|
(18 |
) |
Tablet Accessories |
|
|
64,239 |
|
|
65,157 |
|
(1 |
) |
|
|
198,252 |
|
|
185,945 |
|
7 |
|
Headsets |
|
|
41,762 |
|
|
46,736 |
|
(11 |
) |
|
|
123,023 |
|
|
137,429 |
|
(10 |
) |
Other (3) |
|
|
49,444 |
|
|
59,172 |
|
(16 |
) |
|
|
120,088 |
|
|
167,391 |
|
(28 |
) |
Total Net Sales |
|
$ |
1,255,473 |
|
$ |
1,269,925 |
|
(1 |
)% |
|
$ |
3,286,980 |
|
$ |
3,578,741 |
|
(8 |
)% |
(1) |
|
The Company has reclassified certain prior period amounts to conform to the current period presentation. |
(2) |
|
Gaming includes streaming services revenue generated by Streamlabs. |
(3) |
|
Other primarily consists of mobile speakers and PC speakers. |
LOGITECH INTERNATIONAL S.A. |
|
|
|
|
|
|
|
|
||||||||
PRELIMINARY RESULTS* |
|
|
|
|
|
|
|
|
||||||||
(In thousands, except per share amounts) - unaudited |
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
SUPPLEMENTAL FINANCIAL INFORMATION |
|
Three months ended
|
|
Nine months ended
|
||||||||||||
GAAP TO NON-GAAP RECONCILIATION(A) |
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
||||||||
Gross profit - GAAP |
|
$ |
526,780 |
|
|
$ |
477,268 |
|
|
$ |
1,341,044 |
|
|
$ |
1,375,651 |
|
Share-based compensation expense |
|
|
2,189 |
|
|
|
1,324 |
|
|
|
6,066 |
|
|
|
4,228 |
|
Amortization of intangible assets |
|
|
2,441 |
|
|
|
3,168 |
|
|
|
8,569 |
|
|
|
9,355 |
|
Gross profit - Non-GAAP |
|
$ |
531,410 |
|
|
$ |
481,760 |
|
|
$ |
1,355,679 |
|
|
$ |
1,389,234 |
|
|
|
|
|
|
|
|
|
|
||||||||
Gross margin - GAAP |
|
|
42.0 |
% |
|
|
37.6 |
% |
|
|
40.8 |
% |
|
|
38.4 |
% |
Gross margin - Non-GAAP |
|
|
42.3 |
% |
|
|
37.9 |
% |
|
|
41.2 |
% |
|
|
38.8 |
% |
|
|
|
|
|
|
|
|
|
||||||||
Operating expenses - GAAP |
|
$ |
304,705 |
|
|
$ |
300,523 |
|
|
$ |
883,925 |
|
|
$ |
956,026 |
|
Less: Share-based compensation expense |
|
|
18,424 |
|
|
|
14,481 |
|
|
|
58,126 |
|
|
|
47,512 |
|
Less: Amortization of intangible assets and acquisition-related costs |
|
|
2,276 |
|
|
|
2,810 |
|
|
|
8,279 |
|
|
|
9,052 |
|
Less: Restructuring charges, net |
|
|
839 |
|
|
|
5,654 |
|
|
|
2,562 |
|
|
|
16,471 |
|
Operating expenses - Non-GAAP |
|
$ |
283,166 |
|
|
$ |
277,578 |
|
|
$ |
814,958 |
|
|
$ |
882,991 |
|
|
|
|
|
|
|
|
|
|
||||||||
% of net sales - GAAP |
|
|
24.3 |
% |
|
|
23.7 |
% |
|
|
26.9 |
% |
|
|
26.7 |
% |
% of net sales - Non-GAAP |
|
|
22.6 |
% |
|
|
21.9 |
% |
|
|
24.8 |
% |
|
|
24.7 |
% |
|
|
|
|
|
|
|
|
|
||||||||
Operating income - GAAP |
|
$ |
222,075 |
|
|
$ |
176,745 |
|
|
$ |
457,119 |
|
|
$ |
419,625 |
|
Share-based compensation expense |
|
|
20,613 |
|
|
|
15,805 |
|
|
|
64,192 |
|
|
|
51,740 |
|
Amortization of intangible assets and acquisition-related costs |
|
|
4,717 |
|
|
|
5,978 |
|
|
|
16,848 |
|
|
|
18,407 |
|
Restructuring charges, net |
|
|
839 |
|
|
|
5,654 |
|
|
|
2,562 |
|
|
|
16,471 |
|
Operating income - Non-GAAP |
|
$ |
248,244 |
|
|
$ |
204,182 |
|
|
$ |
540,721 |
|
|
$ |
506,243 |
|
|
|
|
|
|
|
|
|
|
||||||||
% of net sales - GAAP |
|
|
17.7 |
% |
|
|
13.9 |
% |
|
|
13.9 |
% |
|
|
11.7 |
% |
% of net sales - Non-GAAP |
|
|
19.8 |
% |
|
|
16.1 |
% |
|
|
16.5 |
% |
|
|
14.1 |
% |
|
|
|
|
|
|
|
|
|
||||||||
Net income - GAAP |
|
$ |
244,684 |
|
|
$ |
140,153 |
|
|
$ |
444,528 |
|
|
$ |
323,080 |
|
Share-based compensation expense |
|
|
20,613 |
|
|
|
15,805 |
|
|
|
64,192 |
|
|
|
51,740 |
|
Amortization of intangible assets and acquisition-related costs |
|
|
4,717 |
|
|
|
5,978 |
|
|
|
16,848 |
|
|
|
18,407 |
|
Restructuring charges, net |
|
|
839 |
|
|
|
5,654 |
|
|
|
2,562 |
|
|
|
16,471 |
|
Loss on investments |
|
|
604 |
|
|
|
1,488 |
|
|
|
12,213 |
|
|
|
13,065 |
|
Non-GAAP income tax adjustment |
|
|
(29,963 |
) |
|
|
16,230 |
|
|
|
(22,033 |
) |
|
|
23,296 |
|
Net income - Non-GAAP |
|
$ |
241,494 |
|
|
$ |
185,308 |
|
|
$ |
518,310 |
|
|
$ |
446,059 |
|
|
|
|
|
|
|
|
|
|
||||||||
Net income per share: |
|
|
|
|
|
|
|
|
||||||||
Diluted - GAAP |
|
$ |
1.55 |
|
|
$ |
0.86 |
|
|
$ |
2.80 |
|
|
$ |
1.96 |
|
Diluted - Non-GAAP |
|
$ |
1.53 |
|
|
$ |
1.14 |
|
|
$ |
3.26 |
|
|
$ |
2.71 |
|
|
|
|
|
|
|
|
|
|
||||||||
Shares used to compute net income per share: |
|
|
|
|
|
|
|
|
||||||||
Diluted - GAAP and Non-GAAP |
|
|
157,440 |
|
|
|
162,529 |
|
|
|
158,843 |
|
|
|
164,427 |
|
LOGITECH INTERNATIONAL S.A. |
|
|
|
|
|
|
|
|
||||||||
PRELIMINARY RESULTS* |
|
|
|
|
|
|
|
|
||||||||
(In thousands) - unaudited |
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
||||||||
SUPPLEMENTAL FINANCIAL INFORMATION |
|
Three months ended
|
|
Nine months ended
|
||||||||||||
SHARE-BASED COMPENSATION EXPENSE |
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
||||||||
Share-based Compensation Expense |
|
|
|
|
|
|
|
|
||||||||
Cost of goods sold |
|
$ |
2,189 |
|
|
$ |
1,324 |
|
|
$ |
6,066 |
|
|
$ |
4,228 |
|
Marketing and selling |
|
|
8,878 |
|
|
|
8,014 |
|
|
|
28,623 |
|
|
|
25,240 |
|
Research and development |
|
|
4,421 |
|
|
|
2,756 |
|
|
|
13,568 |
|
|
|
11,568 |
|
General and administrative |
|
|
5,125 |
|
|
|
3,711 |
|
|
|
15,935 |
|
|
|
10,704 |
|
Total share-based compensation expense |
|
|
20,613 |
|
|
|
15,805 |
|
|
|
64,192 |
|
|
|
51,740 |
|
Income tax benefit |
|
|
(3,391 |
) |
|
|
(3,276 |
) |
|
|
(11,257 |
) |
|
|
(7,496 |
) |
Total share-based compensation expense, net of income tax benefit |
|
$ |
17,222 |
|
|
$ |
12,529 |
|
|
$ |
52,935 |
|
|
$ |
44,244 |
|
*Note: These preliminary results for the three and nine months ended December 31, 2023 are subject to adjustments, including subsequent events that may occur through the date of filing our Quarterly Report on Form 10-Q. |
(A) Non-GAAP Financial Measures
To supplement our condensed consolidated financial results prepared in accordance with GAAP, we use a number of financial measures, both GAAP and non-GAAP, in analyzing and assessing our overall business performance, for making operating decisions and for forecasting and planning future periods. We consider the use of non-GAAP financial measures helpful in assessing our current financial performance, ongoing operations and prospects for the future as well as understanding financial and business trends relating to our financial condition and results of operations.
While we use non-GAAP financial measures as a tool to enhance our understanding of certain aspects of our financial performance and to provide incremental insight into the underlying factors and trends affecting both our performance and our cash-generating potential, we do not consider these measures to be a substitute for, or superior to, the information provided by GAAP financial measures. Consistent with this approach, we believe that disclosing non-GAAP financial measures to the readers of our financial statements provides useful supplemental data that, while not a substitute for GAAP financial measures, can offer insight in the review of our financial and operational performance and enables investors to more fully understand trends in our current and future performance. In assessing our business during the quarter ended December 31, 2023 and prior periods presented, we excluded items in the following general categories, each of which are described below:
Share-based compensation expense. We believe that providing non-GAAP measures excluding share-based compensation expense, in addition to the GAAP measures, allows for a more transparent comparison of our financial results from period to period. We prepare and maintain our budgets and forecasts for future periods on a basis consistent with this non-GAAP financial measure. Further, companies use a variety of types of equity awards as well as a variety of methodologies, assumptions and estimates to determine share-based compensation expense. We believe that excluding share-based compensation expense enhances our ability and the ability of investors to understand the impact of non-cash share-based compensation on our operating results and to compare our results against the results of other companies.
Amortization of intangible assets. We incur intangible asset amortization expense, primarily in connection with our acquisitions of various businesses and technologies. The amortization of purchased intangibles varies depending on the level of acquisition activity. We exclude these various charges in budgeting, planning and forecasting future periods and we believe that providing the non-GAAP measures excluding these various non-cash charges, as well as the GAAP measures, provides additional insight when comparing our gross profit, operating expenses, and financial results from period to period.
Acquisition-related costs. We incurred expenses and credits in connection with our acquisitions which we generally would not have otherwise incurred in the periods presented as a part of our continuing operations. Acquisition-related costs include certain incremental expenses incurred to effect a business combination. We believe that providing the non-GAAP measures excluding these costs and credits, as well as the GAAP measures, assists our investors because such costs are not reflective of our ongoing operating results.
Restructuring charges (credits), net. These expenses are associated with restructuring plans, and will vary based on the initiatives in place during any given period. Restructuring charges may include costs related to employee terminations, facility closures and early cancellation of certain contracts as well as other costs resulting from our restructuring initiatives. We believe that providing the non-GAAP measures excluding these items, as well as the GAAP measures, assists our investors because such charges (credits) are not reflective of our ongoing operating results.
Loss (gain) on investments. We recognize losses (gains) related to our investments in various companies, which vary depending on the operational and financial performance of the companies in which we invest. These amounts include our losses (earnings) on equity method investments, investment impairments and losses (gains) resulting from sales or other events related to our investments. We believe that providing the non-GAAP measures excluding these items, as well as the GAAP measures, assists our investors because such losses (gains) are not reflective of our ongoing operations.
Non-GAAP income tax adjustment. Non-GAAP income tax adjustment primarily measures the income tax effect of non-GAAP adjustments excluded above as well as the income tax impact of non-recurring deferred taxes, tax settlements, and other non-routine tax events, the determination of which is based upon the nature of the underlying items. For the three and nine months ended December 31, 2023, non-GAAP income tax adjustment included the tax benefit from a remeasurement of the tax basis of goodwill under the Swiss Federal Act on Tax Reform and AHV Financing (“TRAF”) based on an agreement reached with the Swiss Tax Authority during the three months ended December 31, 2023.
Each of the non-GAAP financial measures described above, and used in this press release, should not be considered in isolation from, or as a substitute for, a measure of financial performance prepared in accordance with GAAP. Further, investors are cautioned that there are inherent limitations associated with the use of each of these non-GAAP financial measures as an analytical tool. In particular, these non-GAAP financial measures are not based on a comprehensive set of accounting rules or principles and many of the adjustments to the GAAP financial measures reflect the exclusion of items that are recurring and may be reflected in the Company’s financial results for the foreseeable future. We compensate for these limitations by providing specific information in the reconciliation included in this press release regarding the GAAP amounts excluded from the non-GAAP financial measures. In addition, as noted above, we evaluate the non-GAAP financial measures together with the most directly comparable GAAP financial information.
Additional Supplemental Financial Information - Constant Currency
In addition, Logitech presents percentage sales growth in constant currency to show performance unaffected by fluctuations in currency exchange rates. Percentage sales growth in constant currency is calculated by translating prior period sales in each local currency at the current period’s average exchange rate for that currency and comparing that to current period sales.
(LOGIIR)
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240122556101/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
